Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MadeMed vs MEDVidi

MadeMed
Graded #30

Higher grade

vs+22.400000000000006
MEDVidi
Graded #384

Lower grade

The verdict

MadeMed takes it — 80.4/100 to 58/100.

MadeMed grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Publishes its price at every single dose, so what a titrated dose costs is knowable on day one.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMadeMed +29
74
45
Dose & formulationMadeMed +37
90
53
Clinical oversightMadeMed +7
84
77
Labs & monitoringEven
62
62
FulfillmentMadeMed +31
90
59
Contract termsMadeMed +33
88
55
MadeMed · left barMEDVidi · right bar

The numbers

MetricMadeMedMEDVidi
WeighScore80.4/10058/100
GradeB−C
Scorecard rank#30#384
Semaglutide$239/mo quarterly (from $199/mo on 6 months)Not disclosed
Tirzepatide$399/mo quarterly (from $369/mo on 6 months)Not disclosed
Coverage40 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
MadeMed

Graded #30 · B−

Strengths

  • One flat price at every dose, published dose by dose — semaglutide 0.25–2.4mg, tirzepatide 2.5–15mg
  • LegitScript verified, with board-certified physician review and US compounding pharmacies
  • Full refund minus a $39 visit fee if you are not prescribed, stated before checkout
  • Oral semaglutide and oral tirzepatide alongside the injections; free overnight shipping with supplies

Where it loses points

  • The most expensive tirzepatide here at $399/mo quarterly
  • 40 states rather than nationwide
  • No published recurring lab programme
  • Ships one vial every two months, a less flexible cadence than a monthly refill
MEDVidi

Graded #384 · C

Strengths

  • Licensed providers can prescribe brand-name Zepbound and Wegovy
  • Transparent flat consultation fees (195 dollar initial, 159 dollar follow-up)
  • Prescriptions sent to the patient's pharmacy of choice, so insurance can be used

Where it loses points

  • Consult-fee model: medication is not included and its cost is separate
  • No medication pricing is published
  • State list is shown as a map rather than enumerated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard